Followers | 1077 |
Posts | 90220 |
Boards Moderated | 6 |
Alias Born | 07/26/2007 |
Friday, November 26, 2021 10:03:17 AM
The old OS was 357,521,582 shares on 08/09/2021 (see the first link below) but the New OS was diluted to 439,590,272 shares on 11/05/2021 (see the second link below) and the Latest OS from the TA was 447,551,068 shares as of 11/22/2021 (see the third link below)!
So total 90,029,486 shares were diluted within just Three months and total 7,960,796 shares were diluted within only Seventeen days!
https://www.otcmarkets.com/filing/html?id=15147650&guid=GEywkHWfXB7fJth
https://www.otcmarkets.com/filing/html?id=15336431&guid=GEywkHWfXB7fJth
https://www.otcmarkets.com/stock/TNXP/security
Again, this Huge Diluting Pos Scam will further crash to $0.4 in the coming days/weeks...
Sell ASAP before it is too late --- breaking down $0.455!
Stock-Killers-World has spot 442 stock killers from 9000-Bagger to 2.2-Bagger since 03/05/2011
Recent TNXP News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 12:05:14 PM
- Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) • GlobeNewswire Inc. • 10/17/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/16/2024 01:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:05:35 PM
- Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:05:22 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/01/2024 04:15:07 AM
- Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAI • GlobeNewswire Inc. • 09/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 11:05:27 AM
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines • GlobeNewswire Inc. • 09/27/2024 11:00:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/23/2024 09:09:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:08:50 AM
- Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/20/2024 09:03:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 11:05:26 AM
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:23:27 AM
- Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/13/2024 09:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:05:24 AM
- Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 11:07:15 AM
- Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta • GlobeNewswire Inc. • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:17:58 PM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM